Kitazato Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Kitazato Corporation's yearly results (2023–2026), compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 9.7 times. Higher than 96% of Healthcare companies in Japan.
- Tangible Net Worth Ratio: Of every ¥100 of net worth, ¥100 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than 90% of Healthcare companies in Japan.
- Tangible Assets Ratio: Of every ¥100 the company owns, ¥100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 86% of Healthcare companies in Japan.
Where ¥100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
¥102Over the last 3 years, every ¥100 of reported profit came with ¥102 of operating cash.
Lower than 71% of Healthcare companies in Japan.
Self-Funding Ratio
9.7×Over the last 3 years its own operating cash covered its investment spending (capex) 9.7 times.
Higher than 96% of Healthcare companies in Japan.
Cash Locked Ratio
¥22For every ¥100 of sales, ¥22 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ¥23 tied up three years earlier.
More money tied up than 58% of Healthcare companies in Japan.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 71% of Healthcare companies in Japan.
Growth Efficiency Ratio
¥33Sales grew 17% in 3 years; of every extra ¥100 of sales, ¥33 became extra profit.
Higher than 85% of Healthcare companies in Japan.
Asset Productivity Ratio
+17% / +42%In 3 years sales changed by +17% while total assets changed by +42%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
100%Of every ¥100 the company owns, ¥100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 86% of Healthcare companies in Japan.
Tangible Net Worth Ratio
100%Of every ¥100 of net worth, ¥100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 90% of Healthcare companies in Japan.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Kitazato Corporation owes ¥0.05 for every ¥1 it owns. Net profit rose 3% in the year to Mar 2026, and grew 5% a year on average over 3 years.
Compared with Healthcare companies in Japan · latest annual results Mar 2026.
P/E ratio
12.2Investors pay ¥12.2 for every ¥1 of Kitazato Corporation's yearly profit, lower than 70% of Healthcare companies in Japan.
P/B ratio
2.54The share price is 2.54 times Kitazato Corporation's book value per share, higher than 73% of Healthcare companies in Japan.
Market cap
¥50.6 BThe total market value of all of Kitazato Corporation's shares at today's price (share price × number of shares), larger than 66% of Healthcare companies in Japan. PosiCap size class: Mini Cap.
Net worth (book value)
¥19.9 BWhat Kitazato Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥496.77Net worth divided by the number of shares. The share price of ¥1,264 is 2.5 times this, which is the P/B above.
Return on equity (ROE)
22.3%Kitazato Corporation earned 22.3% on its shareholders' money over the last year, higher than 92% of Healthcare companies in Japan.
Owes vs Owns
0.05×Kitazato Corporation owes ¥0.05 for every ¥1 it owns (low), lower than 97% of Healthcare companies in Japan.
Dividend yield
2.92%Kitazato Corporation pays 2.92% of its share price as dividends a year, higher than 54% of dividend-paying Healthcare companies in Japan.
Revenue growth
+6%Revenue rose 6% in the year to Mar 2026, and grew 5% a year on average over 3 years.
Profit growth
+3%Net profit rose 3% in the year to Mar 2026, and grew 5% a year on average over 3 years.
Profit margin
35.6%Kitazato Corporation keeps ¥36 of every ¥100 of revenue as net profit.
Cash quality
0.99×Cash from Kitazato Corporation's business was 0.99× its reported profit in the year to Mar 2026 — less cash came in than the profit reported.
Interest cover
5859.0×Kitazato Corporation's operating profit covered its interest costs 5859.0 times in the year to Mar 2026.
Questions
What is Kitazato Corporation's P/E ratio?
Investors pay ¥12.2 for every ¥1 of Kitazato Corporation's yearly profit, lower than 70% of Healthcare companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Kitazato Corporation: ¥50.6 B ÷ ¥19.9 B (30 Jun 2026) = 2.5.
What is Kitazato Corporation's return on equity?
Kitazato Corporation earned 22.3% on its shareholders' money over the last year, higher than 92% of Healthcare companies in Japan.
How much does Kitazato Corporation owe compared with what it owns?
Kitazato Corporation owes ¥0.05 for every ¥1 it owns (low), lower than 97% of Healthcare companies in Japan.
Does Kitazato Corporation pay a dividend?
Yes. Kitazato Corporation pays 2.92% of its share price as dividends a year, higher than 54% of dividend-paying Healthcare companies in Japan.
Is Kitazato Corporation's revenue growing?
Revenue rose 6% in the year to Mar 2026, and grew 5% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.